EFFICACY AND SAFETY OF LY2951742 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY IN PATIENTS WITH MIGRAINE

被引：0

作者：

Skljarevski, V. ^{[1
]}

Oakes, T. ^{[1
]}

Ferguson, M. ^{[2
]}

Zhang, Q. ^{[3
]}

Martinez, J. ^{[1
]}

Johnson, K. ^{[4
]}

Schacht, A. ^{[5
]}

Due, M. ^{[6
]}

Goadsby, P. ^{[7
]}

Dodick, D. ^{[8
]}

机构：

[1] Eli Lilly & Co, Pain Team Med, Indianapolis, IN 46285 USA

[2] Eli Lilly & Co, Clin Operat, Scarborough, ON, Canada

[3] Eli Lilly & Co, Stat Neurosci, Indianapolis, IN 46285 USA

[4] Eli Lilly & Co, Pain Migraine, Indianapolis, IN 46285 USA

[5] Eli Lilly & Co, Elanco, Indianapolis, IN 46285 USA

[6] Eli Lilly & Co, Global Sci Commun, Indianapolis, IN 46285 USA

[7] Kings Coll London, Dept Neurol, London, England

[8] Mayo Clin, Dept Neurol, Phoenix, AZ USA

来源：

CEPHALALGIA | 2016年 / 36卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EHMTC-0110

引用

页码：42 / 42

页数：1

共 50 条

[31] Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial
Chmielewska-Wilkon, Danuta
Reggiardo, Giorgio
Egan, Colin Gerard
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12283 - 12291
[32] Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
Li, Yi-Fan
Hu, Hui-Min
Wang, Bo-Ning
Zhang, Yi
Liu, Xing
Mao, Peng
Fan, Bi-Fa
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[33] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Yu, Shengyuan
Ran, Ye
Wan, Qi
Yang, Xiaosu
Chen, Huisheng
Wang, Hebo
Hu, Xueqiang
Mao, Shanping
Yu, Tingming
Luo, Guogang
Guan, Yangtai
Gao, Xuguang
Li, Xin
Zhou, Muke
Li, Yu
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
[34] HPG1860 in patients with NASH: a phase II double-blind, placebo-controlled, dose-ranging study
Alkhouri, Naim
Liu, Yongheng
Liang, Nian
Zhai, Peibin
Wu, Sandra
Zhou, Xin
Xu, Michael
Liu, Que
Harrison, Stephen
JOURNAL OF HEPATOLOGY, 2023, 78 : S812 - S812
[35] EFFICACY OF NISOLDIPINE IN STABLE ANGINA - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED DOSE-RANGING AND RANDOMIZED DOUBLE-BLIND-STUDY
DIBIANCO, R
GLASSER, SP
SMITH, V
THADANI, U
CIRCULATION, 1985, 72 (04) : 275 - 275
[36] EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study
Ratziu, Vlad
Rinella, Mary E.
Neuschwander-Tetri, Brent A.
Lawitz, Eric
Denham, Douglas
Kayali, Zeid
Sheikh, Aasim
Kowdley, Kris, V
Desta, Taddese
Elkhashab, Magdy
DeGrauw, Jeffery
Goodwin, Bryan
Ahmad, Alaa
Adda, Nathalie
JOURNAL OF HEPATOLOGY, 2022, 76 (03) : 506 - 517
[37] Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study
Baker, R
Jasinski, M
Maciag-Tymecka, I
Michalowska-Mrozek, J
Bonikowski, M
Carr, L
MacLean, J
Lin, JP
Lynch, B
Theologis, T
Wendorff, J
Eunson, P
Cosgrove, A
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2002, 44 (10): : 666 - 675
[38] A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia
Marberger, Michael
Chartier-Kastler, Emmanuel
Egerdie, Blair
Lee, Kyu-Sung
Grosse, Joachim
Bugarin, Denise
Zhou, Jihao
Patel, Anand
Haag-Molkenteller, Cornelia
EUROPEAN UROLOGY, 2013, 63 (03) : 496 - 503
[39] Rituximab in rheumatoid arthritis: A double-blind, placebo-controlled, dose-ranging trial.
Emery, P
Fleischmann, RM
Filipowicz-Sosnowska, A
Schechtman, J
Ramos-Remus, C
Gomez-Reino, JJ
Hessey, EW
Shaw, TM
Li, NF
Agarwal, S
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S709 - S709
[40] Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial
Croop, Robert
Madonia, Jennifer
Stock, David A.
Thiry, Alexandra
Forshaw, Micaela
Murphy, Abigail
Coric, Vladimir
Lipton, Richard B.
HEADACHE, 2022, 62 (09): : 1153 - 1163

← 1 2 3 4 5 →